Figure 1. Cell Control Percentage of Human IFN-gamma (11725-HNAS) Protein Production Process.
Figure 2. Cytotoxicity Test of Human TNF-alpha / TNFA (10602-HNAE) Protein Production Process.
Figure 3. The Inhibition Percentage of Human LIF (14890-H08H) Protein Production Process.
Figure 4. Cell Viability of Human IFNB1 (10704-H02H) Protein Production Process.
Catalogue | Product name | Purity | Endotoxin |
CT014-H2508H | Human ITGA5 & ITGB1 Heterodimer Protein | > 90 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
10481-H08H | Human TNFRSF4 / OX40 / CD134 Protein (His Tag) | > 90 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
50976-M08H | Mouse NBL1 / DAND1 / DAN Protein (His Tag) | > 95 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
80243-R02H | Rat TrkB / NTRK2 Protein (Fc Tag) | > 92 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
90251-C02H | Cynomolgus PD-L1 / B7-H1 / CD274 Protein (Fc Tag) | > 95 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
50446-M08H | Mouse CD80 / B7-1 / CD28LG Protein (His Tag) | > 97 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
50010-M03H | Mouse PD-L1 / B7-H1 / CD274 Protein (His & Fc Tag) | > 97 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
10804-H08H1 | Human TGFB1 (LAP) / TGF-beta 1 Protein (His Tag) | > 95 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
50810-M08H | Mouse CD123 / IL3RA Protein (ECD, His Tag) | > 95 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
10186-H02H | Human CD147 / EMMPRIN / Basigin Protein (Fc Tag) | > 97 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
10084-H05H | Human PD-L1 / B7-H1 / CD274 Protein (ECD, Fc Tag) | > 95 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
10051-H08H | Human ANPEP / CD13 Protein (603 Met/Ile, His Tag) | > 97 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
11188-H08H | Human B7-H3 / CD276 Protein (His Tag) | > 98 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
80451-R08H | Rat SELP / selectin P / P-selectin Protein (His Tag) | > 95 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
90846-C02H | Rhesus OX40 / CD134 Protein (Fc Tag) | > 90 % as determined by SDS-PAGE | < 1.0 EU/μg protein |
Stem Cells are characterised by their two properties of capability of renewing themselves and differentiating into a diverse range of cell types. The two broad types of mammalian stem cells are: embryonic stem cells and somatic or adult stem cells. Embryonic stem cells are isolated from the inner cell mass of blastocysts, while adult stem cells are found in adult tissues. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, dividing essentially without limit to replenish specialized cells. Because of their pluripotency and unlimited capacity for self-renewal, embryonic stem cell therapies have been proposed for regenerative medicine and tissue replacement after injury or disease. Reprogramming of somatic cells with defined factors can be a resolution to the problem of allogeneic stem cell transplantation in embryonic stem cell therapies. Adult cells, which have been genetically reprogrammed to an embryonic stem cell–like state by being forced to express genes and factors important for maintaining the defining properties of embryonic stem cells, are referred to as induced pluripotent stem cells (iPSCs).